EDIT:NASDAQ
Editas Medicine Inc
2,17 US$
arrow_upward
+1,40%(+0,030) 1D
13 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,14 US$
High
2,21 US$
Low
2,01 US$
Mkt. cap
334,92 მლნ.
Avg. vol.
2,42 მლნ.
Volume
2,79 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
2,14 US$
High
2,21 US$
Low
2,01 US$
Mkt. cap
334,92 მლნ.
Avg. vol.
2,42 მლნ.
Volume
2,79 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
TradingKey
·
5 საათის წინ
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
2 საათის წინ
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
TradingView
·
10 საათის წინ
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Traders Union
·
10 საათის წინ
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc